Home
|
Inbox
|
Search
|
Event
MK-7264, a P2X3 Receptor Antagonist, Reduces Cough Frequency in Patients with Refractory Chronic Cough: Results from a Randomized, Controlled, Phase 2b Clinical Trial
Monday
May
22
11:00 AM
11:15 AM
Type : Late Breaking Abstract |
Speaker(s)
|
Home
|
Inbox
|
Search
|